Katsuyoshi Matsuoka

23PUBLICATIONS
107CO-AUTHORS
GlycoconjugatesQuery processing and optimisationClinical pharmacology and therapeuticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Sep 21, 2026
Using Pre-Study Patient Interviews to Refine Electronic Patient-Reported Outcomes in Clinical Research of Ustekinumab Induction for Ulcerative Colitis (SIRIUS Study).

|May 12, 2026
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

|Feb 24, 2026
Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study.

Katsuyoshi Matsuoka, Erina Hata, Toshihiko Kaise

|Dec 22, 2025
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status.

Katsuyoshi Matsuoka, Satoshi Motoya, Shinichiro Shinzaki

|Sep 22, 2025
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study).

Katsuyoshi Matsuoka, Fumihito Hirai, Kenji Watanabe

Pageof 4

Frequent Collaborators

8 joint publications

Tadakazu Hisamatsu

6 joint publications

Toshifumi Hibi

5 joint publications

Taku Kobayashi

4 joint publications

Shinichiro Shinzaki